Cypridina was first characterized by Dr Osamu and Akemi Shimomura from “Umi Hotaru” Japanese Sea Fireflies in 1966. These are bottom dwelling ostracods that emit a light stream into water when disturbed presumably to deter predation. Cypridina Luciferase was first cloned by Eric Thompson, and S. Nagata under Fred Tsuji in Japan 1989. Cypridina is a 555 amino acid, 62.171 KDa protein that oxidizes the luciferin to produce blue light at 462 nm Em Max. The advantage of using the Cypridna system: it does not cross react with Coelenterazine or Firefly d-Luciferin so it may be used in multiplex assays, brighter then Firefly LuciferasennThe advantages of lyophilized luciferins are:nnpre-aliquoted in small amounts, fresh substrate for every set of experimentsnlong shelf-life (packed under Argon)nfaster to dissolve due to its fine crystal structurenconsistent quality between aliquotes
產(chǎn)品描述
Lyophilized Cypridina Luciferin 99% pure. Identical to Vargula Luciferin. 10 mg, (2 x 5mgs)
產(chǎn)品形式
305-10 Cypridina產(chǎn)品形式查看提供的datasheet
保存建議
室溫
其他
NanoLight&Technologies公司是Prolume Ltd公司的分公司,公司由Prolume Ltd公司創(chuàng)始人Dr. Bruce Bryan等共同創(chuàng)立。Nanolight&Technology公司生產(chǎn)和銷售天然,發(fā)光海洋生物蛋白或海洋生物發(fā)光物質(zhì)。NanoLight 專注于為藥廠、農(nóng)用化學(xué)品及科研試劑生產(chǎn)企業(yè)提供高性價比的檢測試劑。nnNanoLight公司產(chǎn)品應(yīng)用包括高通量藥物開發(fā)、基因組功能研究、腫瘤成像、放射性同位素替代品以及分子診斷。NanoLight產(chǎn)品的一個廣泛的應(yīng)用是通過NanoLight 報告系統(tǒng)研究活細胞中基因和分子功能,通過這種方法為藥廠研究藥物活性提供了一種創(chuàng)新性的解決方法。nnNanoLight產(chǎn)品的另外一個應(yīng)用是為廣大科研人員減少使用放射性試劑,用NanoLight公司的基于發(fā)光報告系統(tǒng)作為替代品。由于以上應(yīng)用,NanoLight產(chǎn)品得到了科研客戶的廣泛信賴。